Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06701422 · ClinicalTrials.gov registry record · NA
Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery
A NA study of Cervical Spinal Cord Injury and Tetraplegia/Tetraparesis, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 2
- Study locations
NCT06701422: Recruiting NA study of Cervical Spinal Cord Injury and Tetraplegia/Tetraparesis, sponsored by Columbia University.
NCT06701422 is a NA study of Cervical Spinal Cord Injury and Tetraplegia/Tetraparesis that is actively recruiting participants, run by Columbia University. The registered enrollment target is 36 participants, above the 20-participant average among 18 other Cervical Spinal Cord Injury trials with a reported enrollment target (80% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06701422, a NA study of Cervical Spinal Cord Injury and Tetraplegia/Tetraparesis, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 2
- Study locations
Study Summary
The proposed study seeks to understand how the cervical spinal cord should be stimulated after injury through short-term physiology experiments that will inform a preclinical efficacy trial. The purpose of this study is to determine which cervical levels epidural electrical stimulation (EES) should target to recruit arm and hand muscles effectively and selectively in spinal cord injury (SCI).
Primary Outcome
Efficacy of stimulation is calculated as 1/threshold for provoking an motor evoked potentials. The threshold will be calculated from the recruitment curves.
Conditions Studied
Interventions
- PROCEDURE Intraoperative stimulation of the cervical spinal cord
Study Locations (2)
New York
- Columbia University Irving Medical Center - New York
- The Daniel and Jane Och Spine Hospital at NewYork-Presbyterian/Allen - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-12-06 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06701422 shows while recruiting
NCT06701422 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, above the 20-participant average among 18 other Cervical Spinal Cord Injury trials with a reported enrollment target (80% higher).
The record links to 3 conditions, with Cervical Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which Intraoperative stimulation of the cervical spinal cord is the first listed.
NCT06701422 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06701422 about?
NCT06701422 is a clinical study titled "Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery". The proposed study seeks to understand how the cervical spinal cord should be stimulated after injury through short-term physiology experiments that will inform a preclinical efficacy trial. The purpose of this study is to determine which cervical levels epidural electrical stimulation (EES) should ...
What is the current status of trial NCT06701422?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2024-12-06. Estimated completion is 2026-06-30.
What conditions does trial NCT06701422 study?
This clinical trial studies the following conditions: Cervical Spinal Cord Injury, Tetraplegia/Tetraparesis, Cervical Myelopathy.
What interventions are being tested in trial NCT06701422?
The interventions under investigation include: Intraoperative stimulation of the cervical spinal cord (PROCEDURE).
Who is sponsoring clinical trial NCT06701422?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06701422 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06701422's enrollment target sits among peer trials
36 4th of 18 higher than 15 of 18 other Cervical Spinal Cord Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cervical Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Precise Robotically IMplanted Brain-Computer InterfacE
RECRUITING · NA
-
Neurostimulation for Respiratory Function After Spinal Cord Injury
RECRUITING · NA
-
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
RECRUITING · NA
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)
RECRUITING · NA
-
Augmenting Rehabilitation Outcomes and Functional Neuroplasticity Using Epidural Stimulation of Cervical Spinal Cord
RECRUITING · NA
-
A User-friendly, Non-invasive Neuro-orthosis That Restores Volitionally Controlled Grasp Functions for SCI Survivors With Tetraplegia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI